Replacement of an Indole Scaffold Targeting Human 15-Lipoxygenase-1 Using Combinatorial Chemistry.
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Your vote was cast
Thank you for your feedback
Thank you for your feedback
MetadataShow full item record
AbstractHuman 15-lipoxygenase-1 (15-LOX-1) belongs to the class of lipoxygenases, which catalyze oxygenation of polyunsaturated fatty acids, such as arachidonic and linoleic acid. Recent studies have shown that 15-LOX-1 plays an important role in physiological processes linked to several diseases such as airway inflammation disease, coronary artery disease, and several types of cancer such as rectal, colon, breast and prostate cancer. In this study, we aimed to extend the structural diversity of 15-LOX-1 inhibitors, starting from the recently identified indolyl core. In order to find new scaffolds, we employed a combinatorial approach using various aromatic aldehydes and an aliphatic hydrazide tail. This scaffold-hopping study resulted in the identification of the 3-pyridylring as a suitable replacement of the indolyl core with an inhibitory activity in the micromolar range (IC50=16±6 μm) and a rapid and efficient structure-activity relationship investigation.
CitationHelv Chim Acta. 2019 May;102(5):e1900040. doi: 10.1002/hlca.201900040. Epub 2019 May 2.
AffiliationHIPS, Helmholtz-Institut für Pharmazeutische Forschung Saarland, Universitätscampus E8.1 66123 Saarbrücken, Germany.
JournalHelvetica Chimica Acta
The following license files are associated with this item:
- Creative Commons
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-ShareAlike 4.0 International
- A combinatorial approach for the discovery of drug-like inhibitors of 15-lipoxygenase-1.
- Authors: van der Vlag R, Guo H, Hapko U, Eleftheriadis N, Monjas L, Dekker FJ, Hirsch AKH
- Issue date: 2019 Jul 15
- Anacardic acid derived salicylates are inhibitors or activators of lipoxygenases.
- Authors: Wisastra R, Ghizzoni M, Boltjes A, Haisma HJ, Dekker FJ
- Issue date: 2012 Aug 15
- Identification of 6-benzyloxysalicylates as a novel class of inhibitors of 15-lipoxygenase-1.
- Authors: Eleftheriadis N, Thee S, te Biesebeek J, van der Wouden P, Baas BJ, Dekker FJ
- Issue date: 2015 Apr 13
- Kinetics of inhibition of leukocyte 12-lipoxygenase by the isoform-specific inhibitor 4-(2-oxapentadeca-4-yne)phenylpropanoic acid.
- Authors: Moody JS, Marnett LJ
- Issue date: 2002 Aug 13
- An overview of lipoxygenase inhibitors with approach of in vivo studies.
- Authors: Orafaie A, Mousavian M, Orafai H, Sadeghian H
- Issue date: 2020 Jun